mail
Print view
 

Intermittent Fasting: Benefits May Be Less Dramatic in Humans than in Animal Studies

bbc.com

Intermittent fasting has been linked to weight loss and a range of possible health benefits, from improved metabolic health to lower risks of cancer and cognitive decline. However, evidence from human studies remains inconsistent, and researchers say the effects appear to be far less dramatic than those seen in animal experiments. 

Human evidence remains mixed

Intermittent fasting can involve fasting on certain days of the week or restricting food intake to specific hours of the day. It has gained a reputation as a potentially easier way to lose weight than standard calorie restriction.

However, recent studies have produced conflicting results. Depending on the study, intermittent fasting has been reported as more effective, less effective or, in some cases, potentially harmful. Researchers therefore caution that it should not be regarded as a “magic” solution.

Around 5% weight loss in humans

According to Krista Varady, professor of nutrition at the University of Illinois at Chicago, intermittent fasting produces around 5% weight loss in humans, depending on the method used. This is roughly as effective as other diet strategies.

Even relatively modest weight loss can bring metabolic benefits, including reductions in cholesterol and blood pressure. Intermittent fasting may also lessen symptoms of polycystic ovary syndrome. At the same time, more intensive forms, such as alternate-day fasting, may reduce lean body mass.

Animal studies show stronger effects

Many of the most striking findings on intermittent fasting come from studies in mice, flies and worms. In animal models, restricted eating periods have been associated with healthier ageing even when calorie intake remained unchanged.

In humans, however, the evidence has been less conclusive. Researchers point to fundamental biological differences, including the much higher metabolic rate of mice. A 16-hour fast in a rodent may correspond to several days of fasting in a human.

Cancer and cognition findings remain uncertain

Research into cognitive benefits also shows a gap between animal and human data. Cancer research has likewise produced mixed results.

Animal studies have linked intermittent fasting to cancer prevention and greater resilience during chemotherapy, but a major study testing a fasting-mimicking approach in humans did not reproduce the expected metabolic effect.

At the same time, the 5:2 diet may help women with metastatic breast cancer during chemotherapy, including in terms of quality of life and slower disease progression.

A major problem: knowing what people actually eat

One of the largest obstacles in nutrition research is the difficulty of measuring food intake accurately. Most human studies rely heavily on food diaries and self-reporting.

Participants may forget meals or underreport what they have eaten. One analysis from 2025 suggested that around 30% of people underreport their food intake, with average underreporting ranging from about 400 to more than 800 calories.

New technologies could improve future studies

Researchers are increasingly testing technologies that could provide more objective information about eating behaviour. These include cameras worn on glasses or necklaces, devices that detect chewing, smart forks and tooth-mounted nutrient sensors.

Blood and urine testing can also provide more objective information about nutrients being processed by the body. Researchers are now studying whether combinations of food diaries, biomarkers and wearable devices could produce results closer to those obtained in tightly controlled inpatient trials.

Better data needed before stronger conclusions

Researchers argue that future clinical trials should collect more detailed information not only on food intake and adherence, but also on physical activity and sleep.

For now, the available evidence suggests that intermittent fasting can support weight loss and improve some metabolic markers, but its broader health benefits in humans remain less certain than popular claims and animal studies might suggest.

Read the full article here. 

Furhter Information: 

 

Autor: Sally Adee   Quelle: bbc.com (14.08.26; GI-NH)
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichisches Rotes KreuzÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)Charité International AcademyAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Health Forum GasteinÖsterreichische Gesellschaft für Public Health